Pharmaceutical composition for the inhibition of ocular angiogenesis comprising rivoceranib and method for inhibition of ocular angiogenesis using the same

摘要

The present invention relates to a pharmaceutical composition for suppressing ocular neovascularization comprising riboceranib and a method for suppressing ocular neovascularization using the same, wherein the eye drops containing riboceranib as an active ingredient include corneal neovascularization area and Since it reduces the neovascular index and reduces the number and area of blood vessels and lymphatic vessels in the corneal tissue, it can be effectively used to suppress corneal neovascularization.